These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2878258)

  • 1. Cyclosporin metabolites and nephrotoxicity.
    Leunissen KM; Beuman GH; Bosman F; van Hooff JP
    Lancet; 1986 Dec; 2(8520):1398. PubMed ID: 2878258
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine nephrotoxicity.
    Bennett WM; Pulliam JP
    Ann Intern Med; 1983 Dec; 99(6):851-4. PubMed ID: 6360003
    [No Abstract]   [Full Text] [Related]  

  • 3. Does nifedipine ameliorate cyclosporin A nephrotoxicity?
    Kwan JT; Foxall PJ; Townend JN; Bending MR; Eisinger AJ
    Br Med J (Clin Res Ed); 1987 Oct; 295(6602):851. PubMed ID: 3119066
    [No Abstract]   [Full Text] [Related]  

  • 4. Does nifedipine ameliorate cyclosporin A nephrotoxicity?
    Feehally J; Walls J; Mistry N; Horsburgh T; Taylor J; Veitch PS; Bell PR
    Br Med J (Clin Res Ed); 1987 Aug; 295(6593):310. PubMed ID: 3115427
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular lesions as manifestations of cyclosporin nephrotoxicity.
    Moody H; Matz L; Hurst P
    Lancet; 1986 May; 1(8491):1221-2. PubMed ID: 2871465
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cyclosporin-induced nephrotoxicity].
    Heering P; Grabensee B
    Dtsch Med Wochenschr; 1988 May; 113(20):833-4. PubMed ID: 3286182
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis.
    Furlanut M; Baraldo M; Galla F; Marzocchi V; Pea F
    Pharmacol Res; 1996 Jun; 33(6):349-52. PubMed ID: 8971957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A nephrotoxicity.
    Dieperink H
    Dan Med Bull; 1989 Jun; 36(3):235-48. PubMed ID: 2666036
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydergine and cyclosporin nephrotoxicity.
    Nussenblatt RB; Austin HA; Palestine AG; Preuss HG
    Lancet; 1986 May; 1(8491):1220-1. PubMed ID: 2871464
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nephrotoxicity of cyclosporin. Clinical, physiopathological and histological aspects].
    Ben Hmida M; Deray G; Brillet G; Faucher C; Beaufils H; Jacobs C
    Ann Med Interne (Paris); 1991; 142(4):288-94. PubMed ID: 1929054
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of cyclosporin nephrotoxicity by diuretic therapy.
    Deray G; Baumelou B; Le Hoang P; Aupetit B; Girard B; Baumelou A; Legrand JC; Jacobs C
    Clin Nephrol; 1989 Jul; 32(1):47. PubMed ID: 2758701
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nephrotoxicity of pristinamycin-cyclosporin interaction in renal transplant patients].
    Gagnadoux MF; Loirat C; Pillion G; Bertheleme JP; Pouliquen M; Guest G; Broyer M
    Presse Med; 1987 Oct; 16(35):1761. PubMed ID: 2962095
    [No Abstract]   [Full Text] [Related]  

  • 13. Itraconazole and cyclosporin nephrotoxicity.
    Nováková I; Donnelly P; de Witte T; de Pauw B; Boezeman J; Veltman G
    Lancet; 1987 Oct; 2(8564):920-1. PubMed ID: 2889119
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differential diagnosis of rejection and cyclosporin nephrotoxicity in organ transplantation using exfoliative urinary cytology].
    Stella F; Alfani D; Stella C; Battistelli S; Troccoli R; Cortesini R
    Quad Sclavo Diagn; 1985 Sep; 21(3):330-40. PubMed ID: 3915106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood pharmacokinetic parameters of cyclosporin A and nephrotoxicity. Diagnostic and predictive value in renal transplantation].
    Serre-Debeauvais F; Benzekri S; Alix JL; Vialtel P; Gavend M
    Therapie; 1988; 43(1):9-13. PubMed ID: 3282342
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies.
    Rosano TG; Pell MA; Freed BM; Dybas MT; Lempert N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):330-8. PubMed ID: 3284076
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporin-induced nephrotoxicity and hypertension.
    Sturrock ND; Lang CC; Struthers AD
    Br J Hosp Med; 1992 Oct 21-Nov 3; 48(8):483-5, 488-9. PubMed ID: 1422559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary cytologic abnormalities in bone marrow transplant recipients of cyclosporin.
    Stella F; Troccoli R; Stella C; Battistelli S; Biagioni S; Giardini C; Baronciani D; Manenti F
    Acta Cytol; 1987; 31(5):615-9. PubMed ID: 3314304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients.
    Taube DH; Neild GH; Williams DG; Cameron JS; Hartley B; Ogg CS; Rudge CJ; Welsh KI
    Lancet; 1985 Jul; 2(8448):171-4. PubMed ID: 2862369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood cyclosporin concentrations and renal allograft dysfunction.
    Holt DW; Marsden JT; Johnston A; Bewick M; Taube DH
    Br Med J (Clin Res Ed); 1986 Oct; 293(6554):1057-9. PubMed ID: 3094774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.